Edesa Biotech
EDSA
12 hedge funds and large institutions have $1.83M invested in Edesa Biotech in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 3 closing their positions.
20% less funds holding
Funds holding: 15 → 12 (-3)
48% less capital invested
Capital invested by funds: $3.49M → $1.83M (-$1.66M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$372K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$65K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
-$5.03K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
| 5 |
Morgan Stanley
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
1
Anson Funds Management
Dallas,
Texas
| $1.71M | -$372K | -444 | -15% |
|
|
AG
2
Advisor Group
Phoenix,
Arizona
| $94K | -$5.03K | -6 | -4% |
|
3
UBS Group
Zurich,
Switzerland
| $9K | -$1.68K | -2 | -13% |
|
4
Creative Planning
Overland Park,
Kansas
| $4K | – | – | – |
|
|
WP
5
WealthPLAN Partners
Omaha,
Nebraska
| $2.22K | – | – | – |
|
|
ASN
6
Advisory Services Network
Atlanta,
Georgia
| $2K | – | – | – |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | – | – | – |
|
8
Bank of America
Charlotte,
North Carolina
| $1K | -$839 | -1 | -33% |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1K | -$839 | -1 | -33% |
|
|
EDRH
10
Edmond de Rothschild Holding
Chambesy,
Switzerland
| $1K | – | – | – |
|
|
EDRS
11
Edmond de Rothschild (Suisse)
Geneva,
Switzerland
| $1K | – | – | – |
|
|
WAM
12
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| $1K | – | – | – |
|
|
VKH
13
Virtu KCG Holdings
New York
| – | -$65K | -58 | Closed |
|
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4K | -3 | Closed |
|
|
15
Morgan Stanley
New York
| – | -$2K | -2 | Closed |
|
EDSA Hedge Fund Activity: Q3 2016 in Review
12 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2016, worth a combined $1.83M — down 48% from $3.49M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of EDSA and 0 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 0 added.
The largest seller was Anson Funds Management, cutting an estimated $372K.
- 12 institutional investors held Edesa Biotech (EDSA) as of Q3 2016, down from 15 in Q2 2016.
- Funds reported $1.83M of Edesa Biotech stock for Q3 2016, down 48% quarter-over-quarter.
- 0 funds opened new Edesa Biotech positions in Q3 2016 and 3 closed out, a net change of -3 holders.
- The largest Edesa Biotech seller in Q3 2016 was Anson Funds Management, an estimated $372K sold.
Based on aggregated 13F filings for Q3 2016.